X4 Pharmaceuticals (XFOR) Tops Q4 EPS by 5c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Citizens launches transportation coverage, names FedEx a top large-cap pick
• SK Hynix vs. Micron deep dive: who wins the AI memory supercycle?
• Erste Group Downgrades The TJX Companies (TJX) to Hold